Effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention and weight in type 2 diabetic patients

K V Hendriksen, Tonny Joran Jensen, P Oturai, B Feldt-Rasmussen

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    8 Citationer (Scopus)

    Abstract

    In type 2 diabetic patients, insulin detemir (B29Lys(ε-tetradecanoyl),desB30 human insulin) induces less weight gain than NPH insulin. Due to the proposed reduction of tubular action by insulin detemir, type 2 diabetic patients should have increased urinary sodium excretion, thereby reducing extracellular volume and body weight when changed from NPH insulin to insulin detemir.
    OriginalsprogEngelsk
    TidsskriftDiabetologia
    Vol/bind55
    Udgave nummer1
    Sider (fra-til)46-50
    Antal sider5
    ISSN0012-186X
    DOI
    StatusUdgivet - 2012

    Citationsformater